Trial intelligence / Profile preview

Intra-articular Lidocaine vs Rehabilitation for TMJD

NCT06328998Not yet recruiting

Sponsor
Copka Sonpashan
Start
Mar 2024
Primary completion
Dec 2024
Modality
Small Molecules
01

Overview

Randomised trial of lidocaine in temporomandibular joint dysfunction (TMD) (2 arms), sponsored by Copka Sonpashan. Primary endpoint: Friction Index at day 15. Planned start Mar 2024; status: not yet recruiting.

02

Drugs

lidocaine
03

Conditions

temporomandibular joint dysfunction (TMD)

Beyond the preview

Go deeper on NCT06328998.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06328998.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call